Form 8-K - Current report:
SEC Accession No. 0000950170-25-090170
Filing Date
2025-06-26
Accepted
2025-06-26 07:08:02
Documents
10
Period of Report
2025-06-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20250626.htm   iXBRL 8-K 54654
  Complete submission text file 0000950170-25-090170.txt   160808

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crsp-20250626.xsd EX-101.SCH 25978
12 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20250626_htm.xml XML 4500
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 251075044
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)